financetom
Business
financetom
/
Business
/
Waldencast Q2 Loss Narrows, Revenue Increases; Shares Rise After-Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Waldencast Q2 Loss Narrows, Revenue Increases; Shares Rise After-Hours
Aug 28, 2024 3:12 AM

05:50 PM EDT, 08/27/2024 (MT Newswires) -- Waldencast ( WALD ) reported a Q2 net loss late Tuesday of $9 million, compared with a loss of $23.5 million a year earlier.

Two analysts polled by Capital IQ expected a $9.8 million loss.

Revenue for the quarter ended June 30 rose to $63.3 million from $49.4 million a year earlier.

Analysts surveyed by Capital IQ expected $58.3 million.

The company's shares were up about 20% in after-hours activity.

Price: 3.5000, Change: +0.60, Percent Change: +20.69

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
L'Oreal 2Q sales rise but depressed China market weighs
L'Oreal 2Q sales rise but depressed China market weighs
Jul 30, 2024
PARIS, July 30 (Reuters) - French cosmetics giant L'Oreal reported a 5.3% rise in second-quarter sales, below expectations and likely further rattling investors already worried about the lack of rebound in the important Chinese market. The Paris-based company, which owns the Maybelline and Lancome brands, said on Tuesday that sales in the quarter reached 10.88 billion euros ($11.75 billion), up...
Merck Lowers Earnings Guidance Despite Raising Revenue Midpoint; Shares Decline Intraday
Merck Lowers Earnings Guidance Despite Raising Revenue Midpoint; Shares Decline Intraday
Jul 30, 2024
01:17 PM EDT, 07/30/2024 (MT Newswires) -- Merck ( MRK ) lowered its 2024 earnings guidance to reflect the costs tied to its Eyebiotech acquisition despite slightly raising its revenue outlook midpoint, while posting stronger-than-expected second-quarter results. The drugmaker now expects full-year adjusted earnings per share in the $7.94 to $8.04 range, down from between $8.53 and $8.65 previously predicted....
US senator wants FAA to conduct thorough review into Boeing oversight
US senator wants FAA to conduct thorough review into Boeing oversight
Jul 30, 2024
WASHINGTON, July 30 (Reuters) - The chair of the Senate Commerce Committee wants the Federal Aviation Administration to conduct a thorough review into its oversight of Boeing ( BA ) and other manufacturers, raising serious questions about the government's scrutiny of the planemaker. Senator Maria Cantwell in a letter seen by Reuters to FAA Administrator Mike Whitaker said the FAA...
Why Symbotic Stock Is Trading Lower Tuesday
Why Symbotic Stock Is Trading Lower Tuesday
Jul 30, 2024
Symbotic, Inc. ( SYM ) stock is trading lower Tuesday after the company reported worse-than-expected 2024 fiscal year third quarter earnings and issued fourth quarter guidance below estimates. What Happened: On Monday after the market closed, Symbotic ( SYM ) reported third quarter financial earnings, including a loss of two cents per share missing analyst estimates of a loss of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved